top of page

Profile

Join date: Oct 29, 2020

Posts

Nov 22, 2016 ∙ 1 min

Epidemiologic Correlates of Mortality among Symptomatic Visceral Leishmaniasis Cases: Findings from

More than 70% cases of visceral leishmaniasis (VL), a parasitic disease transmitted by sand flies, in India are reported from Bihar, a...

Impavido® (miltefosine) is an FDA-approved treatment for cutaneous, mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO

Aritra Das, Morchan Karthick, Shweta Dwivedi

Writer

bottom of page

IMPAVIDO

(miltefosine)

*U.S. residents only

®

Profile

Posts

Aritra Das, Morchan Karthick, Shweta Dwivedi